GDF11 and pulmonary arterial hypertension: In the current study, we therefore aim to identify the systemic or local GDF11 levels in PAH patients and MCT-induced PAH model, to identify key signaling pathways through which GDF11 acts in muscle with a view to developing novel therapies.